|
Volumn 30, Issue 7, 2012, Pages 575-
|
First FDA-approved beta-amyloid diagnostic hits the market.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMYLOID BETA PROTEIN;
CONTRAST MEDIUM;
DIAGNOSTIC AGENT;
ALZHEIMER DISEASE;
DIAGNOSTIC IMAGING;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
NOTE;
UNITED STATES;
ALZHEIMER DISEASE;
AMYLOID BETA-PEPTIDES;
CONTRAST MEDIA;
DIAGNOSTIC IMAGING;
HUMANS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 84871883065
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0712-575 Document Type: Note |
Times cited : (14)
|
References (0)
|